Search by Drug Name or NDC

NDC 15054-1040-05 Increlex 40 mg/4mL Details

Increlex 40 mg/4mL

Increlex is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Ipsen Biopharmaceuticals, Inc.. The primary component is MECASERMIN.

MedlinePlus Drug Summary

Mecasermin injection is used to replace insulin-like growth factor (a natural hormone produced by your body) in children 2 years of age or older whose bodies do not make enough of this hormone and who are short for their age. Mecasermin is a human insulin-like growth factor (hIGF) analog. It works by replacing a hormone that promotes normal growth of bones and tissues.

Related Packages: 15054-1040-05
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Mecasermin Injection

Product Information

NDC	15054-1040
Product ID	15054-1040_f03c94cc-db9b-4da7-838a-ead7711d4fa3
Associated GPIs	30160045002020
GCN Sequence Number	059704
GCN Sequence Number Description	mecasermin VIAL 10 MG/ML SUBCUT
HIC3	P7A
HIC3 Description	INSULIN-LIKE GROWTH FACTOR-1 (IGF-1) HORMONES
GCN	25465
HICL Sequence Number	033207
HICL Sequence Number Description	MECASERMIN
Brand/Generic	Brand
Proprietary Name	Increlex
Proprietary Name Suffix	n/a
Non-Proprietary Name	mecasermin
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	INJECTION, SOLUTION
Route	SUBCUTANEOUS
Active Ingredient Strength	40
Active Ingredient Units	mg/4mL
Substance Name	MECASERMIN
Labeler Name	Ipsen Biopharmaceuticals, Inc.
Pharmaceutical Class	n/a
DEA Schedule	n/a
Marketing Category	BLA
Application Number	BLA021839
Listing Certified Through	2024-12-31

Package

NDC 15054-1040-05 (15054104005)

Pricing Information	N/A
NDC Package Code	15054-1040-5
Billing NDC	15054104005
Package	1 VIAL, MULTI-DOSE in 1 CARTON (15054-1040-5) / 4 mL in 1 VIAL, MULTI-DOSE
Marketing Start Date	2006-01-03
NDC Exclude Flag	N